[1]
Xiaofang, Y.-H. Li·, C.-L. Hou, B.-S. Zhao, and G.-M. Zou, “Anti-programmed cell death 1 or Anti-programmed cell death ligand 1 vs. Sunitinib for the management of advanced renal cell carcinoma :a meta-analysis”, Am J Transl Med, vol. 7, no. 1, pp. 55–63, Mar. 2023.